FDA.reportPublic FDA data

NDC 68071-3298-06 - Doxazosin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
68071-3298
Requested NDC
68071-3298-06
Package NDCs from labels
68071-3298-3, 68071-3298-6, 68071-3298-9, 68071-3298-06
Manufacturer
NuCare Pharmaceuticals, Inc.
Effective date
2024-07-09
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Doxazosin - NuCare Pharmaceuticals, Inc.NuCare Pharmaceuticals, Inc.2024-07-09HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
68071-3298-32023-03-29These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-62023-03-29These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-92023-03-29These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-32023-01-30These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-62023-01-30These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-92023-01-30These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-32021-02-11These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-62021-02-11These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-92021-02-11These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-32021-01-29These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-62021-01-29These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
68071-3298-92021-01-29These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68071-3298-3Doxazosin30 in 1 BOTTLETABLET304
68071-3298-6Doxazosin60 in 1 BOTTLETABLET604
68071-3298-9Doxazosin90 in 1 BOTTLETABLET904

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68071-3298DOXAZOSIN TABLET [NUCARE PHARMACEUTICALS, INC.]4Current NDC, Legacy NDC, 3 package rows20240711_505d3c4c-5506-72cc-e054-00144ff88e88.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 4 · 68 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DoxazosinDOXAZOSINREMEDYREPACK INC.30a6bb83-f91b-4c4f-a849-4f2be3735a0e2026-08-14Warnings, Adverse reactionsExact identifier
application number: ANDA075580
unii: 86P6PQK0MU
DoxazosinDOXAZOSINMajor Pharmaceuticals3354196f-bbcf-4bc5-94f6-e6e8e132acb12026-08-05Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINA-S Medication Solutionsbfea0b5b-9354-490f-88ff-008134077d242026-07-16Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINREMEDYREPACK INC.71815e8f-33ed-4f36-a8ec-d4443151a9d82026-07-08Warnings, Adverse reactionsExact identifier
unii: 86P6PQK0MU
DoxazosinDOXAZOSINGolden State Medical Supply, Inc.54eeef3d-c906-37e7-e063-6294a90afca22026-06-23Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINREMEDYREPACK INC.bf2f7b41-f14d-4fcd-8db3-f507ca6ff78b2026-06-12Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINREMEDYREPACK INC.ec06f008-37a1-4757-a3ee-0b4720912bc42026-06-11Warnings, Adverse reactionsExact identifier
unii: 86P6PQK0MU
DoxazosinDOXAZOSINPD-Rx Pharmaceuticals, Inc.2ea9bb6b-a4f0-496a-b27b-4454167a4b702026-05-13Warnings, Adverse reactionsExact identifier
application number: ANDA075580
unii: 86P6PQK0MU
DoxazosinDOXAZOSINCardinal Health 107, LLC08521333-ff21-45ad-b99e-1f43d945d24d2026-04-24Warnings, Adverse reactionsExact identifier
application number: ANDA075580
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEBryant Ranch Prepack277c3278-4fe2-47ac-9115-15b417325ffd2026-04-13Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINPreferred Pharmaceuticals Inc.2110eec5-949d-4718-ad6d-3629e5db8a072026-04-08Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINPreferred Pharmaceuticals Inc.e046e0b7-f510-4318-9884-034d683864d42026-04-08Warnings, Adverse reactionsExact identifier
application number: ANDA075580
unii: 86P6PQK0MU
DoxazosinDOXAZOSINAvPAKde9ab9a4-d8b8-8b36-e053-2a95a90aaa352026-03-24Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINAvKAREe3d381c1-3b2f-af70-f4e6-08d6202eed252026-03-24Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEBryant Ranch Prepacke2f5d7d2-21aa-4921-8035-da945d3c565c2026-03-04Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINNuCare Pharmaceuticals, Inc.54116886-ea5e-5320-e054-00144ff8d46c2026-02-16Warnings, Adverse reactionsExact identifier
application number: ANDA075580
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATEBryant Ranch Prepack8641cdb1-dc16-4a13-8a84-bc8f6d58b4d42026-02-13Warnings, Adverse reactionsExact identifier
unii: 86P6PQK0MU
DoxazosinDOXAZOSINBryant Ranch Prepack54549d19-6311-4dbb-8622-fd3e5440551a2026-01-29Warnings, Adverse reactionsExact identifier
application number: ANDA075580
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSINNorthwind Health Company, LLCf2b35586-d550-3fcb-e053-2995a90a34032026-01-19Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU
DoxazosinDOXAZOSIN MESYLATENorthwind Health Company, LLCf6c9856e-9154-f349-e053-6294a90a9f2c2026-01-19Warnings, Adverse reactionsExact identifier
rxcui: 197627
unii: 86P6PQK0MU

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.